The Aperta type of neural tube defect: The relevant experience in a local community with the diversity of the presentation

J Med Life. 2023 Oct;16(10):1499-1502. doi: 10.25122/jml-2023-0190.

Abstract

A series of birth defects known as neural tube defects (NTDs) appear when the neural tube fails to fully or partially close during fetal development. In nations without folic acid supplementation, their incidence ranges from 0.5 to 2 per 1,000 births. The purpose of our study is to estimate the prevalence of NTDs and define the workup for newborn infants with an open neural tube in Al-Qadissiyah, Iraq. This 18-year descriptive retrospective analysis included all babies with NTD diagnoses at the Maternity and Child Teaching Hospital in Al-Qadissiyah Governorate, Iraq. Over the research period, 187 cases of NTDs were evaluated. NTDs presented a male predominance and an incidence rate of 9.4 per 1,000 births, with spina bifida (67.9%), encephalocele (24.02%), and anencephaly (8.02%) being the most prevalent defects. The typical gestational age was 36±5, whereas the typical maternal age was 30±5. It should be noted that 29.9% of women did not take folic acid supplements during the first trimester, while one-third of moms did not benefit from medical supervision during pregnancy. In 65.2% of instances, an antenatal diagnosis was made, and cesarean section was the mode of delivery in 87,8% of cases. Other than that, 64.7% of women lived in low socioeconomic conditions, and 67.9% were from rural areas. The relevance of reinforcing and maximizing folic acid measures throughout the periconceptional phase is emphasized by the fact that NTDs require high intensity and advanced care.

Keywords: Neural Tube Defects (NTDs); anencephaly; spina bifida.

MeSH terms

  • Cesarean Section
  • Child
  • Female
  • Folic Acid / therapeutic use
  • Humans
  • Infant, Newborn
  • Male
  • Neural Tube Defects* / diagnosis
  • Neural Tube Defects* / epidemiology
  • Pregnancy
  • Prevalence
  • Retrospective Studies
  • Spinal Dysraphism* / epidemiology

Substances

  • Folic Acid